A coalition of Senate Democrats is moving to prioritize a comprehensive overhaul of the American health care system, focusing heavily on the persistent issue of rising … Read more
Steve Ubl, the long-time leader of the Pharmaceutical Research and Manufacturers of America, is stepping down as CEO of the industry’s most influential trade group. Ubl, … Read more
The federal government is reaching a critical statutory deadline today for the release of the 2027 Medicare Advantage payment regulation. This regulatory framework will serve as … Read more
Colorado lawmakers are considering a legislative effort to exempt orphan drugs from pricing limits, a move that could shield medications for rare diseases from the oversight … Read more
Wall Street responded with immediate enthusiasm this week as health insurer stocks jump on higher Medicare Advantage rates finalized by the federal government. The announcement, which … Read more
For folk musician Murphy Campbell, the digital age’s promise of accessibility has curdled into a targeted campaign of identity theft and financial exploitation. What began as … Read more
Washington D.C. – As former President Donald Trump eyes a potential return to the White House, a key challenge looms: funding his ambitious policy agenda. A … Read more
WASHINGTON — Food and Drug Administration Commissioner Robert Califf, a physician himself, addressed agency staff Wednesday, striking a tone of gratitude and acknowledging a difficult first … Read more
WASHINGTON — The Trump administration is preparing an executive order that would impose a 100% tariff on all prescription drugs and their key ingredients imported from … Read more
The question of birthright citizenship in the United States, a cornerstone of the 14th Amendment, faced a significant challenge this week. But Wednesday’s oral arguments before … Read more
Washington D.C. Is witnessing a flurry of activity surrounding health savings accounts (HSAs) and Medicare Advantage Health Plans (MAHAs), with industry lobbying efforts intensifying even as … Read more
